Invida

  • Menarini succeeds in bid for Invida

    Singapore, Australia, China, Hong Kong, India, Indonesia, Malaysia, New Zealand, South Korea, Taiwan, Thailand, The Philippines, and Vietnam - these are the nations into which the Florence-based Italian multinational Menarini Group (Menarini) shall now be expanding following its acquisition of Invida Group Private Limited of Singapore (Invida).

    Invida | 05 December 2011

  • Invida forms partnership with Roche in Korea

    Invida Group Pte Ltd announced that it has entered into a partnership agreement with Roche for the commercialization and marketing of that company’s primary care portfolio throughout Korea. According to the company, both Invida and Roche will benef…

    Invida | 04 April 2011

  • Sinclair Pharma and Invida Group agree on India partnership deal

    Dermatology collaboration expanded to include India.

    Invida | 22 March 2011

  • Sinclair Pharma, Invida in partnership

    Sinclair Pharma and Invida entered into a long-term partnership for the commercialization of Sinclair’s brands in Asia Pacific. Under the collaboration agreement, Invida will be Sinclair’s exclusive partner in eleven markets within the Asia …

    Invida | 11 March 2011

  • Invida in alliance with Amdipharm

    Invida announces that it has entered into an agreement with Amdipharm for the licensing and commercialisation of its proprietary products throughout Asia. Amdipharm specialises in acquiring products from leading pharmaceutical companies that se…

    Invida | 19 July 2010

  • Invida Inaugurates Corporate Headquarters in Singapore

    Singapore-based transnational company, Invida Group, has reaffirmed its commitment to the Asia Pacific region. The company announced, at the inauguration of its corporate headquarters, the expansion of its regional partnerships and consolidation of i…

    Invida | 02 April 2010

  • Invida to Market Antiemetic Patch in Asia Pacific

    Invida Pharmaceutical Holdings, a specialty pharmaceutical company based in Singapore has signed an exclusive license and supply agreement for Sancuso. The product is a patent-protected transdermal patch for the prevention of chemotherapy-induced…

    Invida | 12 February 2009